Nabriva Therapeutics Announces $38 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules by Seini Moimoi | May 29, 2020 | Portfolio News
Largest European Quantitative Study on Peanut Allergy Confirms Significant Need, Burden and Psychosocial Impact of Peanut Allergy on Allergic Individuals and their Caregivers by Seini Moimoi | May 28, 2020 | Portfolio News
Amunix Appoints Anne Keane as Senior Vice President of Regulatory and Quality by Seini Moimoi | May 27, 2020 | Portfolio News
Sierra Oncology Appoints Dr. Stephen Dilly as President and Chief Executive Officer by Seini Moimoi | May 26, 2020 | Portfolio News
Kala Pharmaceuticals Announces FDA Acceptance of New Drug Application for EYSUVIS™ for Dry Eye Disease by Seini Moimoi | May 26, 2020 | Portfolio News